Men, take a break from whatever you're doing and see how many pushups you can do.
How many did you do?
It's a predictor of your heart disease risk.
. 20+ reps is linked to a 75% lower risk
. less than 10, you gotta get off dat ass
Data from 10 yr study of 1,104 men aged 21 to 66.
Pushups outperformed submaximal VO2max at predicting events, likely because pushups capture muscular strength and power on top of fitness, two of the strongest protective biomarkers known.
Limitations: the cohort was middle-aged male firefighters, so do not extend to women, older adults, or sedentary populations. The under 10 group was also older, heavier, and smoked more, so some signal is residual confounding by overall metabolic health.
"Proposed ARMA Bill Aims to Enshrine Strategic Bitcoin Reserve Into Law"
Every time Trump announces a stake or strategic position, the asset gets repriced on the federal sponsorship signal.
Now imagine that reflex applied to $BTC.
If the Strategic Bitcoin Reserve shifts from custodying seized coins to actual buying, Bitcoin will get re-rated as a sovereign reserve asset.
https://t.co/24PFlvXnNX
$IBRX doesnβt need to keep leaning on the ATM right now.
They ended Q1 with ~$381M in cash/marketable securities, raised $102M through the ATM, and still have ~$395M available. That remaining ATM capacity is the cleanest short thesis: unlimited drip dilution into every rally.
If management formally paused ATM issuance through the next major catalyst, it would remove a major overhang and force shorts to underwrite the actual ANKTIVA growth story instead of just selling dilution fear.
Execution still matters. But the stock will never get full credit while the hedge fund shorts think every pump is being sold into by the company.
Pause the ATM through the next major catalyst and the setup completely changes: real science + growing revenue + high short interest + 10+ days to cover is rocket fuel!
10+ days to cover matters a lot!!!
It means shorts cannot all exit cleanly in one session. In fact it would take 10 sessions! A real catalyst just hit. Now pause the ATM issuance, combine that with increasing revenue, regulatory progress, plus institutional buying β> shorts covering demand can easily overwhelm the available float.
High short interest + limited exit liquidity + a broken bear thesis can create a major squeeze!
The FDA needs to upgrade drug reviews for the AI era.
Clinical trials take time. Safety and efficacy data should be properly collected.
But once the data package is submitted, review should not take months by default anymore. With AI-assisted analysis, PDUFA decisions should move in weeks, not quarters.
@drconnealymd Trying to get my father to use all these things to help with his cancer treatments. Which thymus peptides do you use? Can you recommend a good source for alpha -1 and beta-4?
Xynth can now scan the stock market for you 24/7 !
Simply describe what you want monitored in plain English.
Under the hood, we wire Claude Opus 4.7 + Python to 3,000+ live market endpoints to build your custom alert.
The workflow lives in the cloud, hunting your setup the moment it hits.
As part of this launch, we're giving free access to the top 5 most profitable alerts built so far.
RT + comment "Xynth" below to get access β
The Codex promotion for existing Plus subscribers ends today and as a part of this, weβre rebalancing Codex usage in Plus to support more sessions throughout the week, rather than longer sessions in a single day.
The Plus plan will continue to be the best offer at $20 for steady, day-to-day usage of Codex, and the new $100 Pro tier offers a more accessible upgrade path for heavier daily use.